Stockhead on MSN6h
Health Check: Mayne Defenders fight ‘inadequate’ takeover offer
A small group of Mayne Pharma holders reckons US bidder Cosette's $600 million tilt does not capture the upside of ... Read ...
Top vaccine official resigns from FDA, criticizes RFK Jr. for promoting ‘misinformation and lies’
The top vaccine official with the Food and Drug Administration has resigned and criticized the nation's top health official ...
Durham biotech defends lead product after concerns surface
A Durham company is pushing back on media reports questioning the safety of its lead product as the firm begins its commercial launch.
MPR2d
FDA Clears OTC Test for Chlamydia, Gonorrhea and Trichomoniasis
The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...
BioPharma Dive2d
Lilly hits same Alzheimer’s roadblock in Europe as Eisai, Biogen
Key regulators are not recommending Lilly’s Kisunla be cleared for the European market. The company says it plans to appeal ...
Debate over the abortion pill mifepristone resurfaces after Makary confirmed to head the FDA
The FDA-approved abortion pill mifepristone is under scrutiny as the new Republican administration takes charge ...
Entvin AI raises Rs 5 crore in first funding round from Y Combinator
With this funding, Entvin plans to expand its artificial intelligence capabilities and accelerate customer acquisition ...
Humacyte CEO addresses concerns in NYT over FDA approval of Symvess
Dr. Laura Niklason, President and CEO of Humacyte, Inc. (NASDAQ:HUMA), responded to a New York Times (NYSE:NYT) article that questioned the FDA’s approval of Symvess for commercial sales earlier this ...
Managed Healthcare Executive3d
FDA Approves First Drug for Excess Hunger in Prader-Willi Syndrome
Vykat XR will be available in April to treat the intense hunger that is a hallmark of the rare genetic disease Prader-Willi ...
SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments ...